Curavit Clinical Research

Executive Summary

Curavit Clinical Research is a digital health company based in San Francisco that provides a comprehensive suite of clinical research organization (CRO) services centered around its proprietary Virtual Clinical Site (VCS) platform. Founded in 2019, the company enables sponsors to design and execute innovative clinical trials with a focus on accelerating timelines, improving data quality, and enhancing participant experience. By integrating best-in-class tools into a seamless, interoperable system, Curavit offers scalable and efficient solutions for decentralized and hybrid trials, positioning itself as a key player in the rapidly evolving clinical trial landscape. The company addresses the growing demand for decentralized clinical trials (DCTs) driven by the need for faster, more patient-centric research. With the global DCT market projected to expand significantly, Curavit's flexible VCS platform and experienced team provide a strong foundation for growth. While still private and without disclosed funding, the company has established a credible presence in the digital health sector. Its ability to form partnerships with various sponsors and deliver high-quality data positions it well for future expansion. The conviction score reflects the promising yet early-stage nature of the company.

Upcoming Catalysts (preview)

• Q3 2026Announcement of strategic partnership with top-20 pharmaceutical company60% success
• Q4 2026Launch of new VCS platform version with advanced AI capabilities70% success
• Q2 2027Achievement of 100th clinical trial milestone80% success